Takeda Ventures

Investor type

VC / CVC

Founded

1781

AUM

-

Location

Cambridge, Massachusetts, United States

Investment Ticket

$5-10 m

Investment Stage

Seed Pre-seed Series A

Region of investment

North America Europe Asia

ESG Focus

Impact investor
Investor profile last updated: 30 August, 2026

Profile

Takeda Ventures is a venture capital firm based in Japan. It is the corporate venture arm of Takeda Pharmaceutical Company, established to build strategic partnerships and investments in biotechnology and life sciences. The firm operates with a team of experienced investors and scientists who focus on identifying and nurturing innovative healthcare solutions. Its team structure and emphasis on integrating science with investment set it apart in the industry.

Takeda Ventures invests in a diverse range of biotechnology and life sciences sectors, including pharmaceuticals, MedTech, and healthtech, with a primary interest in early-stage companies. The firm looks to partner with companies that align with Takeda's strategic priorities in therapeutic areas such as oncology and immunology. While specific financial figures such as total assets under management are not disclosed, the firm aims to provide strategic support and capital to its portfolio companies through strategic alignment and shared goals.

Notable investments by Takeda Ventures include companies like Denali Therapeutics - focusing on neurodegenerative diseases, and Wave Life Sciences - working on oligonucleotide therapies. The firm has strategically co-invested with like-minded partners and maintained a global outreach to innovative companies around the globe, reinforcing its commitment to advancing healthcare through innovation and collaboration.

Industry

Software Pharmaceuticals Medical Devices Healthcare Services Biotechnology MedTech HealthTech

Contacts

Name
Title
Email
avatar
Ramona Sequeira President, U.S. Business Unit and Global Portfolio Commercialization
President, U.S. Business Unit and Global Portfolio Commercialization
-
avatar
Andrew S. Plump, M.D., Ph.D. Director President, Research & Development
Director President, Research & Development
-
Upgrade to see contacts
avatar
CU8fBHJi72qocZdA CU8fBHJi72qocZdA
CU8fBHJi72qocZdA
avatar
CU8fBHJi72qocZdA CU8fBHJi72qocZdA
CU8fBHJi72qocZdA
avatar
CU8fBHJi72qocZdA CU8fBHJi72qocZdA
CU8fBHJi72qocZdA
Investment-team contacts for Takeda Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Takeda Ventures

Takeda Ventures is a venture capital firm that also operates as a corporate VC (CVC). It backs companies at Seed, Pre-seed and Series A, writing tickets of $5-10 m.
Takeda Ventures is located in Cambridge, Massachusetts, United States.
Takeda Ventures was founded in 1781.
Takeda Ventures invests in companies and startups in Software, Pharmaceuticals, Medical Devices, Healthcare Services, Biotechnology, MedTech, HealthTech.
Takeda Ventures invests in companies and startups in North America, Europe, Asia.
Takeda Ventures invests in companies and startups at Seed, Pre-seed, Series A.
Takeda Ventures usually invests $5-10 m on average.
Yes, Takeda Ventures is impact investor.
Takeda Ventures can be reached through its website takedaventures.com, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Takeda Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Takeda Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.